Annual Corporate Law Center symposium draws thought leaders to UC Law

The Corporate Law Center at the University of Cincinnati College of Law brought back its annual symposium with a bang. Held on Friday, March 7, 2025, the 34th annual event, titled  “The Changing Administrative Landscape: Cause for Business to Celebrate or Worry?", brought together top legal minds, industry leaders and UC Law students for a day of learning, networking and thought-provoking discussions.

The day kicked off with a welcome by the College of Law’s Dean Haider Hamoudi, followed by the keynote address from Lisa Heinzerling, Justice William J. Brennan Professor of Law, Georgetown Law Center. Her topic was “Regulatory Uncertainty and the new Administrative Law."

The keynote address was followed by four panels, featuring top corporate legal counsel, distinguished practitioners and leading scholars who provided insightful discussions on recent developments in administrative law and their impact on business.

Loper Bright & Friends – Good for Business?

  • Lisa Heinzerling, Justice William J. Brennan Professor of Law, Georgetown Law Center
  • Susan Whaley, Chief Legal Officer, Procter & Gamble
  • John Applegate, James L. Calamaras Professor of Law, Indiana University
  • Art McMahon, Partner, Taft
  • Thad Driscoll, EHS Senior Counsel at GE Aerospace
  • Moderator: Neil Taylor, Director, Corporate Law Center, UC Law

Corporate Fiduciary Duties After Corner Post

  • Bridget Dooling, Assistant Professor of Law, Moritz College of Law, The Ohio State University
  • Stephen Ewald, General Counsel, Chief Compliance Officer and Corporate Secretary, Medpace, Inc.
  • Beth Naylor, Partner, Frost, Brown Todd
  • Matt Miner, Executive Vice President and Global Chief Ethics and Compliance Officer, Walmart
  • Moderator: Kate Jackson, Associate Professor of Law, UC Law

Environmental Regulation after Ohio v. EPA

  • Bradford Mank, James B. Helmer Professor of Law, UCLaw
  • Keith Bradley, Partner, Squire, Patton Boggs
  • David Altman, President, Altman Newman
  • Moderator:  Neil Taylor, Director, Corporate Law Center, UC Law

The Future of SEC Enforcement after Jarkesy

  • David Stoelting, Senior Trial Counsel, SEC
  • David Lavan, Partner, Dinsmore & Shohl
  • Scott Young, Partner, Thompson Hine
  • Lynn Bai, Professor of Law, UC Law
  • Moderator: Michael Moeddel, Partner, Taft

Recordings taken from the day will be available soon as a podcast on the CincyLaw Cast, the College of Law’s podcast channel.

Plans are already being made for the 35th annual symposium. Mark your calendar now for Friday, March 6, 2026.  

Special thanks to our partners: the Lindner College of Business and the Association of Corporate Counsel whose efforts helped to further enrich the program.

Additionally, thank you to our event sponsors: Altman Newman Co. LPA, Dinsmore & Shohl, KMK Law, Medpace, Procter and Gamble, Squire Patton Boggs, Taft Law, and Thompson Hine LLP for their support.

Related Stories

1

'Time is brain' again, now for control of intracerebral hemorrhage

February 5, 2026

MedPage Today highlighted research led by the University of Cincinnati's Joseph Broderick that found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).

2

Children exposed to gambling mechanics before they understand money

February 4, 2026

Gambling-style mechanics are becoming a routine part of children’s digital lives, appearing in online games, mobile apps and even sports betting advertisements that surround popular media. University of Cincinnati experts warned in a recent WKRC-TV Local 12 report that long before children understand the value of money, they are learning the emotional highs and lows associated with risk. Online games, such as Roblox and Fortnite, offer fast-paced rewards that can keep children glued to screens.

3

Study: Synthetic protein potentially improves outcomes for certain subgroups following intracerebral hemorrhage

February 4, 2026

The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.